In Mali, malaria is endemic amongst more than 90 percent of the population. The overall goal of the program supported by this grant is to contribute to the reduction of illness and death linked to malaria in Mali. The main activities of the program are intended to add value to efforts already in progress in the country, notably through the purchase and distribution of artemisinin-based combination therapy in response to high resistance to the drug chloroquine that has reached alarming levels. The grant also aims to support training activities for the health workers; and to improve the capacities of the National Program to fight Malaria (PNLP) to achieve its coordinating role at the national level.
|Financier||The Global Fund to Fight AIDS, Tuberculosis and Malaria|
|Organisme d'exécution||Ministry of Health of Mali|
|Source des données||The Global Fund to Fight AIDS, Tuberculosis and Malaria|